VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 100 filers reported holding VANDA PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $237,000 | +82.3% | 28,400 | +176.2% | 0.10% | +218.8% |
| Q2 2015 | $130,000 | -16.7% | 10,281 | -5.7% | 0.03% | -38.5% |
| Q4 2014 | $156,000 | -40.7% | 10,900 | -32.7% | 0.05% | -32.5% |
| Q1 2014 | $263,000 | +39.2% | 16,200 | +6.6% | 0.08% | +14.9% |
| Q4 2013 | $189,000 | -80.1% | 15,200 | -87.1% | 0.07% | -63.0% |
| Q2 2013 | $949,000 | – | 117,400 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,525,476 | $74,263,000 | 4.09% |
| ARMISTICE CAPITAL, LLC | 2,828,000 | $46,407,000 | 2.68% |
| Birchview Capital, LP | 80,000 | $1,313,000 | 0.95% |
| GLOBEFLEX CAPITAL L P | 145,426 | $2,386,000 | 0.45% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 231,733 | $3,803,000 | 0.36% |
| 361 CAPITAL LLC | 77,630 | $1,274,000 | 0.35% |
| CADENCE CAPITAL MANAGEMENT LLC | 152,428 | $2,501,000 | 0.27% |
| BOOTHBAY FUND MANAGEMENT, LLC | 148,000 | $2,429,000 | 0.21% |
| EMERALD ADVISERS, LLC | 258,497 | $4,242,000 | 0.18% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 251,730 | $4,131,000 | 0.17% |